MIMS® is an elegant and minimal invasive procedure at the forefront of interventional glaucoma treatments. Fewer post-op complications allow for effective IOP management. MIMS® is designed to create a sclerostomy similar to trabeculectomy, the gold standard for incisional glaucoma surgery, but with an approach that is less invasive, in terms of tissue damage, and without any implanted material (stent-less). Therefore, complications relating to hyphema and hypotony (such as flat anterior chamber, choroidal effusions and detachments), which are observed in trabeculectomy are expected to occur at a lower incidence and severity with MIMS®. Other post-operative events are expected to be similar to other minimally invasive, stent-less glaucoma treatments.